These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

193 related items for PubMed ID: 1345620

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. The use of recombinant human erythropoietin in predialysis patients.
    Besarab A, Ross RP, Nasca TJ.
    Curr Opin Nephrol Hypertens; 1995 Mar; 4(2):155-61. PubMed ID: 7600046
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Erythropoietin treatment in children with renal failure.
    Van Damme-Lombaerts R, Herman J.
    Pediatr Nephrol; 1999 Feb; 13(2):148-52. PubMed ID: 10229005
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The use of recombinant human erythropoietin in the correction of anemia in predialysis patients and its effect on renal function: a double-blind, placebo-controlled trial.
    Kleinman KS, Schweitzer SU, Perdue ST, Bleifer KH, Abels RI.
    Am J Kidney Dis; 1989 Dec; 14(6):486-95. PubMed ID: 2688405
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The anemia of chronic renal failure: pathophysiology and effects of recombinant erythropoietin.
    Eschbach JW, Haley NR, Adamson JW.
    Contrib Nephrol; 1990 Dec; 78():24-36; discussion 37. PubMed ID: 2225841
    [No Abstract] [Full Text] [Related]

  • 12. Recombinant erythropoietin therapy in renal and nonrenal anemia.
    Erslev AJ.
    West J Med; 1992 Aug; 157(2):195-6. PubMed ID: 1441490
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Efficacy of once- versus thrice-weekly subcutaneous recombinant human erythropoietin in children receiving continuous cycling peritoneal dialysis.
    Ongkingco JR, Ruley EJ, Turner ME, Fragale MR.
    Am J Nephrol; 1994 Aug; 14(1):14-8. PubMed ID: 8017476
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Management of anemia using recombinant human erythropoietin in patients on chronic hemodialysis.
    Cotton SL, Holechek MJ.
    ANNA J; 1989 Dec; 16(7):463-8. PubMed ID: 2604448
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Use of subcutaneous recombinant human erythropoietin in children undergoing continuous cycling peritoneal dialysis.
    Sinai-Trieman L, Salusky IB, Fine RN.
    J Pediatr; 1989 Apr; 114(4 Pt 1):550-4. PubMed ID: 2926567
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.